{"product_id":"gynecological-devices-market-analysis-size-trends-united-states-2023-2029-medsuite-includes-gynecological-endoscope-devices-endometrial-ablation-devices-morcellator-device-market-and-7-more","title":"Gynecological Devices Market Analysis, Size, Trends - United States - 2023-2029 - MedSuite - Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.","description":"\u003cp\u003eGynecological Devices Market Analysis, Size, Trends - United States - 2023-2029 - MedSuite - Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.\u003cbr\u003e\nIn 2022, the gynecological devices market in the United States reached a value of approximately $1.3 billion, driven by nearly 3 million gynecological procedures performed annually. Our extensive research in the medical device market encompassed over 70 gynecological device companies across the United States. Through our comprehensive methodology, we analyzed market sizes, unit sales, company market shares, and developed accurate forecasts.\u003c\/p\u003e\n\n\u003cp\u003eThe complete report suite on the U.S. market for gynecological devices covers a wide range of products, including assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters.\u003c\/p\u003e\n\n\u003cp\u003eDATA TYPES INCLUDED\u003c\/p\u003e\n\n\u003cp\u003eUnit Sales, Average Selling Prices, Market Value \u0026amp; Growth Trends\u003cbr\u003e\nGynecological Procedure Volumes\u003cbr\u003e\nForecasts Until 2029, and Historical Data to 2019\u003cbr\u003e\nMarket Drivers \u0026amp; Limiters for Each Gynecological Device market\u003cbr\u003e\nCompetitive Analysis with Market Shares for Each Segment\u003cbr\u003e\nRecent Mergers \u0026amp; Acquisitions\u003cbr\u003e\nDisease Overviews and Demographic Information\u003cbr\u003e\nCompany Profiles, Product Portfolios and SWOT for Top Competitors\u003c\/p\u003e\n\n\u003cp\u003eU.S. GYNECOLOGICAL DEVICES MARKET INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eAs companies vie for market share, pricing strategies in the gynecological devices industry become crucial. This has led to a downward trend in average selling prices (ASPs) across market segments. Lower prices may entice purchasers to explore alternative solutions, prompting providers of alternative gynecological devices to further reduce their prices in a cross-category price competition. The formation of purchasing groups by clinics has bolstered buyers' leverage, compelling sellers to offer competitive prices to secure broader market access. The competitive landscape puts pressure on sellers to ensure their pricing aligns with buyer expectations and demands.\u003c\/p\u003e\n\n\u003cp\u003eOne significant trend in the U.S. market for gynecological devices is the avoidance, when possible, of hysterectomies as a treatment option. Fibroids and endometriosis affect a significant proportion of women in the United States, with 20-25% of reproductive-age women and 11% of women between 15 and 44 being affected, according to the U.S. National Institutes of Health (NIH). To address these conditions, physicians are increasingly turning to minimally invasive treatments such as hysteroscopic surgeries, uterine artery embolization, and endometrial ablation, when the condition permits. These alternative procedures offer less invasiveness, shorter recovery periods, and have become preferred options for patients seeking to avoid the need for hysterectomy.\u003c\/p\u003e\n\n\u003cp\u003eU.S. GYNECOLOGICAL DEVICES MARKET SHARE INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eHologic, Medtronic, Cooper Surgical, and Minerva Surgical emerged as the dominant players in the U.S. gynecological device market, collectively capturing more than 50% of the total market share.\u003c\/p\u003e\n\n\u003cp\u003eHologic dominated the U.S. gynecological device market with its strong presence in various segments, including global endometrial ablation, hysteroscopic morcellators, endoscopes, and fluid management devices.\u003c\/p\u003e\n\n\u003cp\u003eMedtronic secured the second position, competing in the morcellator and fluid management device markets. Their TruClear™ Hysteroscopic morcellator contributed significantly to their market share in the morcellator device segment.\u003c\/p\u003e\n\n\u003cp\u003eMinerva Surgical held the fourth position, participating in the global endometrial ablation, gynecological endoscope, morcellator, and fluid management markets. Their acquisition of the intrauterine portfolio from Boston Scientific in 2020 further strengthened their position.\u003c\/p\u003e\n\n\u003cp\u003eCooper Surgical emerged as the leading competitor in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments, contributing to their third-leading market share in the U.S. gynecological device market.\u003c\/p\u003e\n\n\u003cp\u003eSEGMENTS COVERED\u003c\/p\u003e\n\n\u003cp\u003eAssisted reproduction technology devices\u003cbr\u003e\nGlobal endometrial ablation\u003cbr\u003e\nUterine fibroid embolization devices\u003cbr\u003e\nGynecological endoscopes\u003cbr\u003e\nGynecological resection electrodes\u003cbr\u003e\nMorcellator devices\u003cbr\u003e\nPelvic floor electrical stimulation devices\u003cbr\u003e\nFluid management devices\u003cbr\u003e\nPelvic organ prolapse repair devices\u003cbr\u003e\nHysterosalpingography (HSG) catheters\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 332 Pages \/ MCW16246344","offer_id":47662887076146,"sku":null,"price":9594.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/gynecological-devices-market-analysis-size-trends-united-states-2023-2029-medsuite-includes-gynecological-endoscope-devices-endometrial-ablation-devices-morcellator-device-market-and-7-more","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}